News for GoodRx Holdings, Inc. (GDRX)

Applied Materials (AMAT) to hold fiscal Q2 2025 earnings call on May 15, 2025. GoodRx (GDRX) launches Community Link for independent pharmacies. Both

On May 13, 2025, UBS analyst Kevin Caliendo updated his outlook on GoodRx Holdings (GDRX), a prominent player in the healthcare technology sector. The analyst h

Total Revenue: $203 million, up 3% year-over-year.Prescription Transactions Revenue: Increased by 2% year-over-year.Manufacturer Solutions Revenue: Increased b

May 08, 2025 / 12:00PM GMTOperator Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx first quarter 2025 earnings call. As a reminder, t

GoodRx (GDRX) delivered earnings and revenue surprises of 0% and 0.19%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Discover what to expect as GoodRx (GDRX) announces Q1 earnings. Get insights into EPS, revenue estimates, and past performance.

GoodRx (GDRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Wells Fargo has revised its price target for GoodRx (GDRX), lowering it from $8 to $7, while maintaining an Overweight rating on the stock. The firm recognizes

We recently published a list of 10 Best Telehealth Stocks to Buy Now. In this article, we are going to take a look at where GoodRx Holdings, Inc.

According to Grand View Research, the telehealth market size in the US was valued at $42.54 billion in 2024.

GoodRx Holdings Inc (GDRX), a prominent platform for medication savings in the U.S., has announced that it will release its first quarter 2025 financial results

We recently compiled a list of the 12 Cash-Rich Penny Stocks To Buy According To Hedge Funds. In this article, we are going to take a look at where GoodRx Holdings, Inc.

We recently compiled a list of the 10 Cash-Rich Small Cap Stocks To Invest In According To Analysts. In this article, we are going to take a look at where GoodRx Holdings, Inc.

GoodRx Holdings Inc's unique digital healthcare platform continues to disrupt the traditional healthcare market.Despite robust offerings, GoodRx faces signific

Revenue (Q4 2024): $198.6 millionFull Year Revenue (2024): $792.3 million, up 6% year-over-yearAdjusted EBITDA (Q4 2024): $67.1 millionFull Year Adjusted EBITD

Feb 27, 2025 / 01:00PM GMTOperator Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx fourth quarter and full year 2024 earnings call. A

GoodRx Holdings, Inc. (NASDAQ:GDRX) Q4 2024 Earnings Conference Call February 27, 2025 8:00 AM ETCompany ParticipantsAubrey Reynolds - Director, IRWendy...

GoodRx (GDRX) delivered earnings and revenue surprises of 0% and 0.62%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," ”œGoodRx,” or the ”œCompany”), the leading prescription savings platform in the U.S., has releas